Cargando…
Optimal design and validation of antiviral siRNA for targeting HIV-1
We propose rational designing of antiviral short-interfering RNA (siRNA) targeting highly divergent HIV-1. In this study, conserved regions within HIV-1 genomes were identified through an exhaustive computational analysis, and the functionality of siRNAs targeting the highest possible conserved regi...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2204037/ https://www.ncbi.nlm.nih.gov/pubmed/17996047 http://dx.doi.org/10.1186/1742-4690-4-80 |
_version_ | 1782148419980099584 |
---|---|
author | Naito, Yuki Nohtomi, Kyoko Onogi, Toshinari Uenishi, Rie Ui-Tei, Kumiko Saigo, Kaoru Takebe, Yutaka |
author_facet | Naito, Yuki Nohtomi, Kyoko Onogi, Toshinari Uenishi, Rie Ui-Tei, Kumiko Saigo, Kaoru Takebe, Yutaka |
author_sort | Naito, Yuki |
collection | PubMed |
description | We propose rational designing of antiviral short-interfering RNA (siRNA) targeting highly divergent HIV-1. In this study, conserved regions within HIV-1 genomes were identified through an exhaustive computational analysis, and the functionality of siRNAs targeting the highest possible conserved regions was validated. We present several promising antiviral siRNA candidates that effectively inhibited multiple subtypes of HIV-1 by targeting the best conserved regions in pandemic HIV-1 group M strains. |
format | Text |
id | pubmed-2204037 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-22040372008-01-17 Optimal design and validation of antiviral siRNA for targeting HIV-1 Naito, Yuki Nohtomi, Kyoko Onogi, Toshinari Uenishi, Rie Ui-Tei, Kumiko Saigo, Kaoru Takebe, Yutaka Retrovirology Short Report We propose rational designing of antiviral short-interfering RNA (siRNA) targeting highly divergent HIV-1. In this study, conserved regions within HIV-1 genomes were identified through an exhaustive computational analysis, and the functionality of siRNAs targeting the highest possible conserved regions was validated. We present several promising antiviral siRNA candidates that effectively inhibited multiple subtypes of HIV-1 by targeting the best conserved regions in pandemic HIV-1 group M strains. BioMed Central 2007-11-08 /pmc/articles/PMC2204037/ /pubmed/17996047 http://dx.doi.org/10.1186/1742-4690-4-80 Text en Copyright © 2007 Naito et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Short Report Naito, Yuki Nohtomi, Kyoko Onogi, Toshinari Uenishi, Rie Ui-Tei, Kumiko Saigo, Kaoru Takebe, Yutaka Optimal design and validation of antiviral siRNA for targeting HIV-1 |
title | Optimal design and validation of antiviral siRNA for targeting HIV-1 |
title_full | Optimal design and validation of antiviral siRNA for targeting HIV-1 |
title_fullStr | Optimal design and validation of antiviral siRNA for targeting HIV-1 |
title_full_unstemmed | Optimal design and validation of antiviral siRNA for targeting HIV-1 |
title_short | Optimal design and validation of antiviral siRNA for targeting HIV-1 |
title_sort | optimal design and validation of antiviral sirna for targeting hiv-1 |
topic | Short Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2204037/ https://www.ncbi.nlm.nih.gov/pubmed/17996047 http://dx.doi.org/10.1186/1742-4690-4-80 |
work_keys_str_mv | AT naitoyuki optimaldesignandvalidationofantiviralsirnafortargetinghiv1 AT nohtomikyoko optimaldesignandvalidationofantiviralsirnafortargetinghiv1 AT onogitoshinari optimaldesignandvalidationofantiviralsirnafortargetinghiv1 AT uenishirie optimaldesignandvalidationofantiviralsirnafortargetinghiv1 AT uiteikumiko optimaldesignandvalidationofantiviralsirnafortargetinghiv1 AT saigokaoru optimaldesignandvalidationofantiviralsirnafortargetinghiv1 AT takebeyutaka optimaldesignandvalidationofantiviralsirnafortargetinghiv1 |